Impact Factor
2.67
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.43
168 total citations
h5-index
14
h5 depth signal
Cited share
58.0%
76 of 131
Total citations
168
Citation footprint
Metric signal
1.37
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Iran
466
China
122
Turkey
14
United States
13
United Kingdom
11
Citing Fields of Research
Immunology
261
Allergies
159
Noncoding RNA
64
Hematology
50
Auto-Inflammatory Disorders
45
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
658
Articles tracked across the journal lifetime
Indexed publication set
131
76 cited publications
Last 12 months
114
16.3 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
Iran
466 citing publications
Leading citing field
Immunology
261 citing publications
Latest tracked publication
15 September 2026
10 recent records available
Coverage & Indexing History
v5n1, Mar. 2006-
v5n1, Mar. 2006-
Research Focus & Classification
Indexed Subjects
Immunology
Allergies
Noncoding RNA
Musculoskeletal Disorders
Auto-Inflammatory Disorders
Issuing & Sponsoring Bodies
Contributor
Iranian Society of Asthma and Allergy
Contributor
Iranian Society of Immunology and Allergy
Contributor
Dānishgāh-i ʻUlūm-i Pizishkī-i Tihrān
Broad Categories
Allergy and Immunology
Allergies
Immunology
Noncoding RNA
Virology
Hematology
Musculoskeletal Disorders
MeSH Descriptors
Allergy and Immunology
Asthma
Hypersensitivity
Immunity
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.18502/ijaai.v25i6.22646
Open DOI
Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis
This meta-analysis was conducted to investigate the efficacy and safety of omalizumab in the treatment of allergic rhinitis in adults. Randomized controlled trials (RCTs) on omalizumab in the treatment of allergic rhinitis in adults were...
02
DOI 10.18502/ijaai.v25i6.22657
Open DOI
CD40L-CD40-Mediated Crosstalk between Eosinophils and Mast Cells Exacerbates Nasal Epithelial Barrier Dysfunction and Inflammatory Injury in Allergic Rhinitis
The research intended to elucidate the synergistic effects of eosinophils (Eos) and mast cells (MCs) on human nasal epithelial cells (HNEpCs) in the context of allergic rhinitis (AR), focusing on inflammation, tight junction protein expr...
03
DOI 10.18502/ijaai.v25i6.22656
Open DOI
Clinical and Immune Features of Pneumocystis Pneumonia with Acute Respiratory Distress Syndrome in Immunocompromised Children
Pneumocystis jirovecii pneumonia (PJP) is a common opportunistic infection in immunocompromised children, often causing acute fulminant pneumonia with respiratory failure. The prognosis of PJP in human immunodeficiency virus (HIV)-negati...
04
DOI 10.18502/ijaai.v25i6.22658
Open DOI
Exploring Anticancer Potential of Anethum graveolens: Effects on Apoptosis and HER2 Expression in Human Gastric Adenocarcinoma
Gastric cancer is among the most prevalent malignancies worldwide, with a poor prognosis in advanced stages. Overexpression of human epidermal growth factor receptor 2 (HER2, also known as ERBB2) and heat shock protein 90 alpha (HSP90AA1...
05
DOI 10.18502/ijaai.v25i6.22659
Open DOI
Knockdown of lncRNA SSTR5-AS1 Regulates Ferroptosis and Immunosuppressive Factor Expression Through STAT3/SLC7A11 Signaling Pathway to Interfere with the Progression of Ovarian Cancer
Long noncoding RNA SSTR5 antisense RNA 1 (lncRNA SSTR5-AS1) is increased in a variety of tumors, but its molecular mechanism in ovarian cancer (OC) remains unreported. lncRNA SSTR5-AS1 and signal transducer and activator of transcription...
06
DOI 10.18502/ijaai.v25i6.22660
Open DOI
Identification and Subtype Analysis of Interleukin-17-related Diagnostic Biomarkers in Atopic Dermatitis Based on WGCNA and Machine Learning
Atopic dermatitis (AD) is a chronic inflammatory skin disease with heterogeneous immune dysregulation. Although interleukin-17 (IL-17) signaling is implicated in AD, IL-17-related diagnostic biomarkers and molecular subtypes remain uncle...
07
DOI 10.18502/ijaai.v25i6.22661
Open DOI
Thymoma-associated Immunodeficiency (Good’s Syndrome)
Good’s syndrome (GS) is a rare immunodeficiency disorder associated with thymoma, characterized by hypogammaglobulinemia and impaired cellular immunity. Due to its variable clinical presentation and lack of clear diagnostic criteria, GS ...
08
DOI 10.18502/ijaai.v25i6.22648
Open DOI
Effects of Laser-assisted Periodontal Flap Surgery on Inflammatory Cytokines and Clinical Outcomes in Periodontitis
The aim of this study was to evaluate the clinical and inflammatory outcomes of minocycline hydrochloride combined with tinidazole in patients with chronic periodontitis. PubMed, Cochrane Library, Embase, CNKI, WanFang Data, and VIP were...
09
DOI 10.18502/ijaai.v25i6.22649
Open DOI
Immune Thrombocytopenia and Treatment-associated Changes in Platelet-associated Antibodies and Cytokine/T-cell Profiles
To evaluate whether adjunctive Modified GuiPi Decoction provides additional benefit to standard immunosuppressive therapy in adult patients with chronic immune thrombocytopenia (ITP). This retrospective cohort study included 120 adult pa...
10
DOI 10.18502/ijaai.v25i6.22650
Open DOI
Predictive Value of Combined Serological Indicators for Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus
Cognitive dysfunction (CD) is a common neuropsychiatric manifestation of systemic lupus erythematosus (SLE), but its early identification lacks objective serological markers. This study aimed to explore the predictive value of combined s...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Official journal of the Iranian Society of Asthma and Allergy and the Immunology, Asthma and Allergy Research Insitutute, 2007- .